Tillotts to market Asacol in Nordic region
This article was originally published in Scrip
Executive Summary
Tillotts Pharma has taken back the rights to Asacol (mesalazine) in the Nordic region after the expiry of an agreement with former distribution and marketing partner Bayer Schering Pharma.